🚨 Negative news for Sun Pharma: 🔎 US FDA issues Form 483 with 8 observations for its Halol facility. 📅 GMP inspection conducted from June 2–13, 2025. Potential compliance concerns ahead. #sunpharma #usfda #pharmanews #halol #breakingnews #healthcare